United Health Products, Inc. Announces Executive Changes
February 24, 2022 at 10:01 pm
Share
United Health Products, Inc. submitted his resignation as a director and Chief Operating Officer of the Company, each effective on February 28, 2022, following their respective deliberations with the Company's other directors and in deference to the Company's ongoing efforts to resolve the previously reported Securities Exchange Commission investigation of the Company and the Company's focus on its future business plans. Neither Mr. Beplate nor Mr. Schiliro had any disagreements with the Company.
United Health Products, Inc. develops, manufactures, and markets a hemostatic gauze for the healthcare and wound care sectors. Its gauze product, HemoStyp, is derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. HemoStyp hemostatic gauze is a flexible, silk-like material that is applied by placing the gauze onto the bleeding tissue. The supple material can be easily folded and manipulated as needed to fit the size of the wound or incision. In surface bleeding and surgical situations, the product quickly converts to a translucent gel that allows the physician or surgeon to monitor the coagulation process. In superficial bleeding situations, HemoStyp can be bonded to an adhesive plastic bandage or integrated into a traditional gauze component to address a range of needs, including traumatic bleeding injuries and prolonged bleeding following hemodialysis. Its customer base includes hospitals, surgery centers, clinics and others.
UNITED HEALTH PRODUCTS, INC. 
